NGM Bio Announces Presentations Featuring Updated Findings from the Ongoing Phase 1a Dose Escalation…
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a…
Read More...
Read More...